-
Je něco špatně v tomto záznamu ?
Extensive, 3.8 Mb-Sized Deletion of 22q12 in a Patient with Bilateral Schwannoma, Intellectual Disability, Sensorineural Hearing Loss, and Epilepsy
J. Trizuljak, J. Duben, I. Blaháková, Z. Vrzalová, KS. Kozubík, J. Štika, L. Radová, V. Bergerová, S. Mejstříková, V. Hořínová, R. Jančálek, Š. Pospíšilová, M. Doubek
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
PubMed Central
od 2010 do Před 6 měsíci
Europe PubMed Central
od 2010 do Před 1 rokem
PubMed
37908896
DOI
10.1159/000528744
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: In contrast with the well-known and described deletion of the 22q11 chromosome region responsible for DiGeorge syndrome, 22q12 deletions are much rarer. Only a few dozen cases have been reported so far. This region contains genes responsible for cell cycle control, chromatin modification, transmembrane signaling, cell adhesion, and neural development, as well as several cancer predisposition genes. CASE PRESENTATION: We present a patient with cleft palate, sensorineural hearing loss, vestibular dysfunction, epilepsy, mild to moderate intellectual disability, divergent strabism, pes equinovarus, platyspondylia, and bilateral schwannoma. Using Microarray-based Comparative Genomic Hybridization (aCGH), we identified the de novo 3.8 Mb interstitial deletion at 22q12.1→22q12.3. We confirmed deletion of the critical NF2 region by MLPA analysis. DISCUSSION: Large 22q12 deletion in the proband encases the critical NF2 region, responsible for development of bilateral schwannoma. We compared the phenotype of the patient with previously reported cases. Interestingly, our patient developed cleft palate even without deletion of the MN1 gene, deemed responsible in previous studies. We also strongly suspect the DEPDC5 gene deletion to be responsible for seizures, consistent with previously reported cases.
Central European Institute of Technology Masaryk University Brno Czech Republic
Outpatient Ward for Genetics Hospital Jihlava Jihlava Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022788
- 003
- CZ-PrNML
- 005
- 20240116163133.0
- 007
- ta
- 008
- 240105s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000528744 $2 doi
- 035 __
- $a (PubMed)37908896
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Trizuljak, Jakub $u Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 245 10
- $a Extensive, 3.8 Mb-Sized Deletion of 22q12 in a Patient with Bilateral Schwannoma, Intellectual Disability, Sensorineural Hearing Loss, and Epilepsy / $c J. Trizuljak, J. Duben, I. Blaháková, Z. Vrzalová, KS. Kozubík, J. Štika, L. Radová, V. Bergerová, S. Mejstříková, V. Hořínová, R. Jančálek, Š. Pospíšilová, M. Doubek
- 520 9_
- $a INTRODUCTION: In contrast with the well-known and described deletion of the 22q11 chromosome region responsible for DiGeorge syndrome, 22q12 deletions are much rarer. Only a few dozen cases have been reported so far. This region contains genes responsible for cell cycle control, chromatin modification, transmembrane signaling, cell adhesion, and neural development, as well as several cancer predisposition genes. CASE PRESENTATION: We present a patient with cleft palate, sensorineural hearing loss, vestibular dysfunction, epilepsy, mild to moderate intellectual disability, divergent strabism, pes equinovarus, platyspondylia, and bilateral schwannoma. Using Microarray-based Comparative Genomic Hybridization (aCGH), we identified the de novo 3.8 Mb interstitial deletion at 22q12.1→22q12.3. We confirmed deletion of the critical NF2 region by MLPA analysis. DISCUSSION: Large 22q12 deletion in the proband encases the critical NF2 region, responsible for development of bilateral schwannoma. We compared the phenotype of the patient with previously reported cases. Interestingly, our patient developed cleft palate even without deletion of the MN1 gene, deemed responsible in previous studies. We also strongly suspect the DEPDC5 gene deletion to be responsible for seizures, consistent with previously reported cases.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Duben, Jakub $u Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Blaháková, Ivona $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Vrzalová, Zuzana $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kozubík, Kateřina Staňo $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Štika, Jiří $u Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Radová, Lenka $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Bergerová, Veronika $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Mejstříková, Soňa $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Hořínová, Věra $u Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Outpatient Ward for Genetics, Hospital Jihlava, Jihlava, Czech Republic
- 700 1_
- $a Jančálek, Radim $u Department of Neurosurgery, St. Anne University Hospital, Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Pospíšilová, Šárka $u Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Doubek, Michael $u Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00191331 $t Molecular syndromology $x 1661-8769 $g Roč. 14, č. 5 (2023), s. 439-448
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37908896 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240105 $b ABA008
- 991 __
- $a 20240116163130 $b ABA008
- 999 __
- $a ok $b bmc $g 2036393 $s 1209233
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 14 $c 5 $d 439-448 $e 20230602 $i 1661-8769 $m Molecular syndromology $n Mol Syndromol $x MED00191331
- LZP __
- $a Pubmed-20240105